Cargando…

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

PURPOSE: Lianhuaqingwen (LH) as traditional Chinese medicine (TCM) formula has been used to treat influenza and exerted broad-spectrum antiviral effects on a series of influenza viruses and immune regulatory effects Ding et al. (2017). The goal of this study is to demonstrate the antiviral activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Runfeng, Li, Yunlong, Hou, Jicheng, Huang, Weiqi, Pan, Qinhai, Ma, Yongxia, Shi, Chufang, Li, Jin, Zhao, Zhenhua, Jia, Haiming, Jiang, Kui, Zheng, Shuxiang, Huang, Jun, Dai, Xiaobo, Li, Xiaotao, Hou, Lin, Wang, Nanshan, Zhong, Zifeng, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102548/ https://www.ncbi.nlm.nih.gov/pubmed/32205232 http://dx.doi.org/10.1016/j.phrs.2020.104761

Ejemplares similares

Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]
por: Runfeng, Li, et al.
Publicado: (2021)

Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
por: Ma, Qinhai, et al.
Publicado: (2020)

Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
por: Ma, Qinhai, et al.
Publicado: (2020)

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
por: Ding, Yuewen, et al.
Publicado: (2017)

Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies
por: Pan, Weiqi, et al.
Publicado: (2018)

Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action
por: Ma, Qinhai, et al.
Publicado: (2022)

Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’
por: Huang, Xi, et al.
Publicado: (2021)

Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
por: Chen, Xiaofei, et al.
Publicado: (2021)

Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation
por: Hua, Chen, et al.
Publicado: (2021)

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
por: Hu, Ke, et al.
Publicado: (2021)

Epidemiological and molecular characterization of dengue viruses imported into Guangzhou during 2009–2013
por: Shi, Yongxia, et al.
Publicado: (2016)

Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
por: Gong, Xiaowei, et al.
Publicado: (2021)

Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates
por: Ma, Qinhai, et al.
Publicado: (2022)

Gene silencing of β-galactosamide α-2,6-sialyltransferase 1 inhibits human influenza virus infection of airway epithelial cells
por: Wu, Dong, et al.
Publicado: (2014)

Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials
por: Fan, Zheng, et al.
Publicado: (2021)

Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2016)

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases
por: Shen, Pan, et al.
Publicado: (2021)

A new perspective to improve the treatment of Lianhuaqingwen on COVID-19 and prevent the environmental health risk of medication
por: Gu, Wenwen, et al.
Publicado: (2022)

A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
por: Zhang, Xiaobo, et al.
Publicado: (2021)

Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections
por: Xie, Peifang, et al.
Publicado: (2021)

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects
por: Ying, Lei, et al.
Publicado: (2021)

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022)

Melatonin exerts anti-angiogenic and anti-inflammatory effects in alkali-burned corneas
por: Meng, Jie, et al.
Publicado: (2022)

Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic
por: Liang, Chengyuan, et al.
Publicado: (2021)

Morphologic and Molecular Characterization of a Strain of Zika Virus Imported into Guangdong, China
por: Li, Shufen, et al.
Publicado: (2017)

Active immunization with Pseudomonas aeruginosa vaccine protects mice from secondary Pseudomonas aeruginosa challenge post-influenza virus infection
por: Wu, Xiaofeng, et al.
Publicado: (2023)

Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
por: Zheng, Jin-ping, et al.
Publicado: (2023)

Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
por: Sun, Jing, et al.
Publicado: (2020)

Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Liang, et al.
Publicado: (2014)

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
por: Fang, Jie, et al.
Publicado: (2020)

Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
por: Liu, Ming, et al.
Publicado: (2021)

The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
por: Du, Qiuling, et al.
Publicado: (2019)

A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants
por: Dong, Yidan, et al.
Publicado: (2022)

Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
por: Lan, Xiao-fang, et al.
Publicado: (2021)

Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin
por: Zhang, Li, et al.
Publicado: (2015)

The clinical efficacy and safety research of Lianhuaqingwen (LHQW) in treatment of COVID-19: A systematic review and meta-analysis
por: Fang, Ling, et al.
Publicado: (2022)

Association between IRGM polymorphisms and tuberculosis risk: A meta-analysis
por: Xie, Haojun, et al.
Publicado: (2017)

Lithium Chloride Exerts Anti-Inflammatory and Neuroprotective Effects by Inhibiting Microglial Activation in LPS-Induced Retinal Injury
por: Wu, Nandan, et al.
Publicado: (2023)

Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro
por: Ma, Qinhai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l37nejb03g8ogqpijd48s3jpc7